| Various cardiovascular diseases and prevention | Çetin EROL | 59–59 |
| Increased cardiovascular risk associated with hyperlipoproteinemia (a) and the challenges of current and future therapeutic possibilities | Zlatko FRAS | 60–69 |
| Aspirin for primary prevention of cardiovascular disease: Advice for a decisional strategy based on risk stratification | Alberto AIMO,Raffaele De CATERINA | 70–78 |
| Ratio of Fabry disease in patients with idiopathic left ventricular hypertrophy: A single-center study in Turkey | Hasan Ali BARMAN,Sevgi Özcan ŞENER,Adem ATICI,Caner ÖZGÖKÇE,Ahmet Muşteba ÖZTÜRK,Ayşegül Ezgi KAFALI,Nafiye Emel ÇAKAR,Mustafa Emir TAVŞANLI,Mehmet Emin KÜÇÜK,Ertuğrul OKUYAN,İrfan ŞAHİN | 79–85 |
| Comparison of clinical outcomes between angiotensin-converting-enzyme inhibitors and ARBs in patients with acute myocardial infarction with dyslipidemia after a successful stent implantation | Yong Hoon KIM,Ae-Young HER,Myung Ho JEONG,Byeong-Keuk KIM,Sung-Jin HONG,Seunghwan KIM,Chul-Min AHN,Jung-Sun KIM,Young-Guk KO,Donghoon CHOI,Myeong-Ki HONG,Yangsoo JANG | 86–98 |
| Screening and evaluation of newly diagnosed cardiovascular diseases in first-trimester asymptomatic pregnant women in a tertiary antenatal care center in Turkey | Veciha Özlem BOZKAYA,Zeynep Aslı OSKOVİ KAPLAN,Emre ÖZGÜ,Yaprak ENGİN ÜSTÜN | 99–104 |
| Ten-year outcome of chronic thromboembolic pulmonary hypertension patients in a tertiary center | Mehmet Serdar KÜÇÜKOĞLU,Ümit Yaşar SİNAN,Bedrettin YILDIZELİ | 105–109 |
| Iodide mumps: A rare complication of iodine-containing contrast after coronary angioplasty | Fatemeh BAHARVAND,Asghar MOHAMADI | 110–111 |
| Delayed diagnosis of short QT syndrome concealed by pacemaker implant due to sick sinus syndrome | İbrahim BAŞARICI | 111–113 |
| Macitentan in the treatment of pulmonary hypertension in Gaucher's disease | Gökay TAYLAN,Meryem AKTOZ,Mehmet Furkan ÇELİK,Mustafa Adem YILMAZTEPE | 114–116 |
| Macitentan in the treatment of pulmonary hypertension in Gaucher's disease |